Vision-Sciences Inc. reported today that it lost $100,000 in its fiscal first quarter, less than the $1.4 million it lost a year ago.
The Orangeburg-based medical-device maker said the reduced loss was primarily the result of a one-time $3 million gain related to sale of assets last year to Medtronic Xomed Inc.
On a per-share basis Vision-Sciencesâ€™ earnings were flat in the current-year quarter, compared to a loss of 4 cents a share a year ago.
Revenues during the quarter, which ended June 30, rose 21 percent to $2.9 million, from $2.4 million last year, it said.
The company’s shares, traded on the Nasdaq Capital Market, ended today’s trading down 4 cents to $4.59 a share.